{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:17:04Z","timestamp":1779909424152,"version":"3.53.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.phrs.2021.105612","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:30:13Z","timestamp":1618792213000},"page":"105612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The effect of tibolone treatment on lipid profile in women: A systematic review and dose-response meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"169","author":[{"given":"Changyu","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea-Alexandru","family":"G\u0103man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-2181","authenticated-orcid":false,"given":"Ahmed","family":"Abu-Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1378\/chest.116.3.847","article-title":"Hormone replacement therapy","volume":"116","author":"Morse","year":"1999","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.phrs.2021.105612_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-5122(98)00059-0","article-title":"Tibolone: a review","volume":"30","author":"Albertazzi","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.phrs.2021.105612_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00044-9","article-title":"Tibolone: a steroid with a tissue-specific mode of action","volume":"76","author":"Kloosterboer","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2021.105612_bib5","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1080\/13697130601114917","article-title":"Menopause and cardiovascular disease: the evidence","volume":"10","author":"Rosano","year":"2007","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib6","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jcem.82.6.3995","article-title":"Tibolone: influence on markers of cardiovascular disease","volume":"82","author":"Bjarnason","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.phrs.2021.105612_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1161\/01.ATV.0000091502.96745.95","article-title":"Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study","volume":"23","author":"Koh","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2021.105612_bib8","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jacc.2005.02.099","article-title":"Hypertension, menopause, and coronary artery disease risk in the Women\u2019s Ischemia Syndrome Evaluation (WISE) Study","volume":"47","author":"Gierach","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2362.2003.01163.x","article-title":"Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial","volume":"33","author":"Ossewaarde","year":"2003","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.phrs.2021.105612_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.1998.tb10237.x","article-title":"A double\u2010blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms","volume":"105","author":"Hammar","year":"1998","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cen.14155","article-title":"Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial","volume":"92","author":"Kotecha","year":"2020","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib13","first-page":"542","article-title":"Effect of short-term tibolone treatment on risk markers for cardiovascular disease in healthy postmenopausal women: a randomized controlled study","volume":"40","author":"Traianos","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib14","first-page":"483","article-title":"Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial","volume":"28","author":"Morais-Socorro","year":"2012","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-0528.2004.00309.x","article-title":"The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial","volume":"112","author":"Kroiss","year":"2005","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib16","first-page":"19","article-title":"The effect of hormone therapy and tibolone on glucose and lipid metabolism in healthy postmenopausal women","volume":"14","author":"\u00c7ayan","year":"2011","journal-title":"Turk. Geriatr. Derg."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.maturitas.2008.12.021","article-title":"Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study","volume":"62","author":"Vieira","year":"2009","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09513590410001667238","article-title":"The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia","volume":"18","author":"Kalogeropoulos","year":"2004","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0015-0282(02)04200-0","article-title":"Effect of tibolone administration on heart rate variability and free fatty acid levels in postmenopausal women","volume":"78","author":"Manzella","year":"2002","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000163045","article-title":"Effects of hormone replacement therapy on insulin resistance and platelet function tests","volume":"18","author":"Sarac","year":"2009","journal-title":"Med. Princ. Pract."},{"issue":"9","key":"10.1016\/j.phrs.2021.105612_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint\u2014preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys. Ther."},{"key":"10.1016\/j.phrs.2021.105612_bib22","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2021.105612_bib23","unstructured":"Higgins\u00a0J.,\u00a0Cochrane Handbook for Systematic Reviews of Interventions,\u00a00,\u00a0version 5,\u00a02011."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"issue":"7109","key":"10.1016\/j.phrs.2021.105612_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2021.105612_bib26","series-title":"Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments","first-page":"127","article-title":"The trim and fill method","author":"Duval","year":"2005"},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s13224-012-0297-7","article-title":"A comparative study of CEE, tibolone, and DHEA as hormone replacement therapy for surgical menopause","volume":"63","author":"Gupta","year":"2013","journal-title":"J. Obstet. Gynecol. India"},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib28","first-page":"281","article-title":"The effects of tibolone on risk factors of cardiovascular disease in menopausal women","volume":"35","author":"Ziaei","year":"2010","journal-title":"Iran. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00404-008-0712-6","article-title":"Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women","volume":"279","author":"Engin-Ust\u00fcn","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10554-009-9429-2","article-title":"Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study","volume":"25","author":"Duygu","year":"2009","journal-title":"Int. J. Cardiovasc. Imaging"},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590701718307","article-title":"The effect of different preparations of hormone therapy on tumor necrosis factor-\u03b1 levels in women with surgical menopause","volume":"24","author":"Somunkiran","year":"2008","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.fjc.0000211747.16573.d5","article-title":"Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma","volume":"47","author":"Christodoulakos","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/eurheartj\/ehi695","article-title":"The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxy-progesterone acetate on progression of carotid intima-media thickness: the osteoporosis prevention and arterial effects of tiboLone (OPAL) study","volume":"27","author":"Bots","year":"2006","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2005.01.131","article-title":"Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women","volume":"84","author":"Osmana\u011fao\u011flu","year":"2005","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib35","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.fertnstert.2003.11.033","article-title":"Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study","volume":"81","author":"Ostberg","year":"2004","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib36","first-page":"47","article-title":"Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women","volume":"61","author":"Anedda","year":"2004","journal-title":"Horm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2265.2003.01666.x","article-title":"Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux","volume":"58","author":"von Eckardstein","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105612_bib38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1161\/01.ATV.0000091502.96745.95","article-title":"Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women \u2013 a randomized, double-blind, placebo-controlled, crossover study","volume":"23","author":"Koh","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.jhh.1000938","article-title":"A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women","volume":"14","author":"Lloyd","year":"2000","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(99)00096-1","article-title":"Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women","volume":"34","author":"Castelo-Branco","year":"2000","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0015-0282(98)00128-9","article-title":"A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata","volume":"70","author":"Palomba","year":"1998","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0029-7844(95)00468-8","article-title":"A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin","volume":"87","author":"Milner","year":"1996","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib43","first-page":"259","article-title":"Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women","volume":"128","author":"Rymer","year":"1993","journal-title":"Acta Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/IGC.0000000000000333","article-title":"Efficacy of raloxifene hydrochloride for the prevention of health care problems in patients who undergo surgery for endometrial cancer: a multicenter randomized clinical trial","volume":"25","author":"Nakamura","year":"2015","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/oby.20653","article-title":"Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes","volume":"22","author":"Van Pelt","year":"2014","journal-title":"Obesity"},{"issue":"14","key":"10.1016\/j.phrs.2021.105612_bib46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/0961203313507987","article-title":"Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial","volume":"22","author":"Mok","year":"2013","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.phrs.2021.105612_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/09513590.2013.788628","article-title":"Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women","volume":"29","author":"Grover-P\u00e1ez","year":"2013","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00404-009-1292-9","article-title":"Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids","volume":"283","author":"Oztas","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2010.143453","article-title":"Raloxifene for prevention of glucocorticoid-induced bone loss: A 12-month randomised double-blinded placebo-controlled trial","volume":"70","author":"Mok","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1536\/ihj.51.60","article-title":"Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women","volume":"51","author":"Sumino","year":"2010","journal-title":"Int. Heart J."},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/gme.0b013e3181e04a18","article-title":"Effects of raloxifene on serum macrophage colony-stimulating factor and interleukin-18 levels in postmenopausal women younger than 60 years","volume":"17","author":"Oztas","year":"2010","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1139\/Y10-002","article-title":"Effects of raloxifene treatment on the phenotype of blood monocytes","volume":"88","author":"Boudjeltia","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2008.09.014","article-title":"Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women","volume":"204","author":"Yasui","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.phrs.2008.03.010","article-title":"Raloxifene has favourable effects on metabolic parameters but has no effect on left ventricular function in postmenopausal women","volume":"57","author":"Oktem","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2362.2007.01905.x","article-title":"Role of raloxifene on platelet metabolism and plasma lipids","volume":"38","author":"Nanetti","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/13697130701750123","article-title":"Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women","volume":"10","author":"Katz","year":"2007","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/gme.0b013e3180577893","article-title":"Raloxifene slows down the progression of intima-media thickness in postmenopausal women","volume":"14","author":"Colacurci","year":"2007","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.phrs.2021.105612_bib58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/09513590601069470","article-title":"Effects of intranasal 17\u03b2-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: a randomized, placebo-controlled clinical trial","volume":"22","author":"Engin-\u00dcst\u00fcn","year":"2006","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijgo.2005.05.005","article-title":"Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women","volume":"90","author":"Yildiz","year":"2005","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13697130500042581","article-title":"Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women","volume":"8","author":"Dias","year":"2005","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/humrep\/deh053","article-title":"Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene","volume":"19","author":"Palomba","year":"2004","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00125-004-1328-4","article-title":"Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women","volume":"47","author":"Lasco","year":"2004","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.phrs.2021.105612_bib63","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","article-title":"Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis","volume":"63","author":"Hern\u00e1ndez","year":"2003","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib64","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0735-1097(03)00776-9","article-title":"Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease","volume":"42","author":"Griffiths","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib65","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1210\/jc.2002-021557","article-title":"Endothelial function and menopause: effects of raloxifene administration","volume":"88","author":"Colacurci","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1067\/mob.2003.83","article-title":"Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women","volume":"188","author":"Cagnacci","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/jcem.87.1.8168","article-title":"Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial","volume":"87","author":"Andersson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1527-3466.2001.tb00183.x","article-title":"Cardiovascular effects of raloxifene hydrochloride","volume":"19","author":"Saitta","year":"2001","journal-title":"Cardiovasc. Drug Rev."},{"issue":"18","key":"10.1016\/j.phrs.2021.105612_bib69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.phrs.2021.105612_bib70","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","article-title":"Treatment of established postmenopausal osteoporosis with raloxifene: a randomized","volume":"13","author":"Lufkin","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2021.105612_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.maturitas.2020.03.007","article-title":"Menopause symptom management in women with dyslipidemias: an EMAS clinical guide","volume":"135","author":"Anagnostis","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.phrs.2021.105612_bib72","article-title":"Tibolone regulates systemic metabolism and the expression of sex hormone receptors in the central nervous system of ovariectomised rats fed with high-fat and high-fructose diet","volume":"2020","author":"Coyoy-Salgado","year":"1748","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/gerona\/gls210","article-title":"Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension","volume":"68","author":"Gilglioni","year":"2013","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib74","first-page":"337","article-title":"The impact of six-month tibolone postmenopausal treatment on cell adhesion molecules levels","volume":"39","author":"Zografou","year":"2012","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105612_bib75","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1515\/CCLM.2006.269","article-title":"Effect of tibolone therapy on lipids and coagulation indices","volume":"44","author":"Daher","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9","key":"10.1016\/j.phrs.2021.105612_bib76","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.clinthera.2019.06.002","article-title":"Lipoprotein(a): current evidence for a physiologic role and the effects of nutraceutical strategies","volume":"41","author":"Santos","year":"2019","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2021.105612_bib77","doi-asserted-by":"crossref","unstructured":"M.A. Gaman, M.E. Epingeac, C.C. Diaconu, A.M. Gaman, Crosstalk between oxidative stress and inflammation in obesity, Rev. Chim., 71(1), pp. 228\u2013232.","DOI":"10.37358\/RC.20.1.7837"},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pcad.2020.04.009","article-title":"Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies","volume":"63","author":"Santos","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"12","key":"10.1016\/j.phrs.2021.105612_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189834","article-title":"Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake","volume":"12","author":"Ced\u00f3","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.phrs.2021.105612_bib80","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1194\/jlr.R200017-JLR200","article-title":"Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet","volume":"44","author":"Deeb","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2021.105612_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110801","article-title":"Effects of intermittent fasting and energy-restricted diets on lipid profile: a systematic review and meta-analysis","volume":"77","author":"Meng","year":"2020","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.phrs.2021.105612_bib82","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/07315724.2018.1444520","article-title":"Impact of diets rich in whole grains and fruits and vegetables on cardiovascular risk factors in overweight and obese women: a randomized clinical feeding trial","volume":"37","author":"Fatahi","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2021.105612_bib83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.nut.2018.08.004","article-title":"Effect of alpha-lipoic acid supplementation on lipid profile: a systematic review and meta-analysis of controlled clinical trials","volume":"59","author":"Mousavi","year":"2019","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.numecd.2019.10.001","article-title":"The impact of probiotic yogurt consumption on lipid profiles in subjects with mild to moderate hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Pourrajab","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"issue":"5","key":"10.1016\/j.phrs.2021.105612_bib85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pcd.2019.05.001","article-title":"The health effects of medical nutrition therapy by dietitians in patients with diabetes: a systematic review and meta-analysis: nutrition therapy and diabetes","volume":"13","author":"Razaz","year":"2019","journal-title":"Prim. Care Diabetes"},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2019.10.002","article-title":"The effects of green coffee bean extract supplementation on lipid profile in humans: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Ding","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib87","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2265.2010.03839.x","article-title":"The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy","volume":"73","author":"Stuckey","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105612_bib88","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105612_bib89","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (high-density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105612_bib90","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11886-017-0940-0","article-title":"HDL cholesterol metabolism and the risk of CHD: new insights from human genetics","volume":"19","author":"Vitali","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6118\/jmm.20000","article-title":"The 2020 menopausal hormone therapy guidelines","volume":"26","author":"Academic Committee of the Korean Society of","year":"2020","journal-title":"J. Menopausal Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib92","first-page":"254","article-title":"Lipid profile status in natural and surgical menopausal women: a comparative study","volume":"29","author":"Paul","year":"2020","journal-title":"Mymensingh Med. J. MMJ"},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5993\/AJHB.45.1.6","article-title":"Impact of menopause and body composition status on dyslipidemia in women","volume":"45","author":"Wooten","year":"2021","journal-title":"Am. J. Health Behav."},{"issue":"9","key":"10.1016\/j.phrs.2021.105612_bib94","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/GME.0000000000001575","article-title":"The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian longitudinal study on aging","volume":"27","author":"Christakis","year":"2020","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.phrs.2021.105612_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010202","article-title":"Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women","volume":"12","author":"Ko","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2021.105612_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/814690","article-title":"Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapy","volume":"2013","author":"Mott","year":"2013","journal-title":"ISRN Endocrinol."},{"issue":"18","key":"10.1016\/j.phrs.2021.105612_bib97","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.2174\/0929867326666190201142321","article-title":"Cardioprotective properties of HDL: structural and functional considerations","volume":"27","author":"Pappa","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105612_bib98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MOL.0000000000000294","article-title":"HDLs in crises","volume":"27","author":"von Eckardstein","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105612_bib99","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MOL.0000000000000432","article-title":"HDL and the menopause","volume":"28","author":"El Khoudary","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105612_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6118\/jmm.20000","article-title":"The 2020 menopausal hormone therapy guidelines","volume":"26","author":"Lee","year":"2020","journal-title":"J. Menopausal Med."},{"issue":"10","key":"10.1016\/j.phrs.2021.105612_bib101","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821001961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821001961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:33:27Z","timestamp":1760913207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821001961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":101,"alternative-id":["S1043661821001961"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105612","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of tibolone treatment on lipid profile in women: A systematic review and dose-response meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105612"}}